Patanjali’s study on Renogrit, that fights cancer drug-induced kidney damage, among 2024’s most notable research papers
A research paper published on Patanjali’s Renogrit, a formulation that is effective against cancer drug cisplatin’s damaging effect on kidneys, has been featured among the most notable research studies of 2024.…
Strides Pharma approves demerger from Arco Labs
Strides Pharma is set to demerge from Arco Labs, a global capability centre, the company said in its exchange filing on Wednesday. Board of Directors of Strides Pharma Science Limited (Strides) and Arco…
Milestone Pharma Expands Sale Agreement, Increases Offering
Milestone Pharmaceuticals Inc. (NASDAQ:MIST), a pharmaceutical company specializing in cardiovascular treatments with a market capitalization of $155.39 million, has amended its sales agreement with Jefferies LLC, effectively increasing its common…
Novo Nordisk regains membership in UK pharma body
London: Danish pharmaceutical giant Novo Nordisk has regained its membership in the UK’s pharmaceutical industry body after serving a two-year suspension for breaching a national drugmakers practice code. The Association of the British…
USV Joins Empagliflozin generic contest, launches its brand Xenia
New Delhi: One of India’s leading anti-diabetic players, USV, has become the latest entrant in the Empagliflozin generic contest with the launch of its version, Xenia, in India. The Indian drug maker…
SMS Hospital revamps blood safety protocols after fatal transfusion error
Jaipur: In the wake of a tragic fatality caused by an erroneous blood transfusion at SMS Hospital in Feb 2024, the institution has overhauled its transfusion safety measures. The Immunohematology…
IIT Roorkee researchers discover potential drug to treat Chikungunya and other mosquito-borne diseases
Indian Institute of Technology (IIT) Roorkee scientists have discovered a potential drug that can possibly be used to treat Chikungunya, a mosquito-borne viral disease that causes fever, joint pain, muscle…
Sun Pharma, Zydus recall products in US
The US Food and Drug Administration (USFDA) has said that Sun Pharma and Zydus Pharmaceuticals are recalling products in the US market due to manufacturing issues. In its latest Enforcement…
Strides Pharma gains 3% as Singapore arm acquires 100% stake in Amexel Pte
Strides Pharma shares gained 2.8 per cent on BSE, logging an intraday high at Rs 603 per share in Tuesday’s trade. The buying interest sparked after the company arm Strides…
Licensing delays pushing medical device makers abroad: Parliament panel
A large number of medical device-manufacturing units have been forced to move to Vietnam and Malaysia due to delays, inconsistent timelines, and a lack of transparency in licensing processes, according…
